Clinical & Pharma

Wales Passes Motion to Regulate Potential Assisted Dying
Clinical & Pharma Wales Passes Motion to Regulate Potential Assisted Dying

The landscape of medical ethics and healthcare governance in Wales underwent a transformative shift following the Senedd’s decision to approve a legislative consent motion regarding the regulation of assisted dying services. This vote, which concluded with 28 members in favor and 23 against,

Yale Researchers Use Pandemic Tech to Faster Detect Tuberculosis
Clinical & Pharma Yale Researchers Use Pandemic Tech to Faster Detect Tuberculosis

Tuberculosis remains one of the most formidable challenges to global health, yet a transformative breakthrough from the Yale School of Public Health now promises to dismantle the barriers that have historically hindered rapid diagnosis and effective treatment. By repurposing genomic sequencing

Can Wales Close the Inequality Gap in Child Dental Health?
Clinical & Pharma Can Wales Close the Inequality Gap in Child Dental Health?

The sight of a five-year-old child suffering from avoidable dental pain serves as a stark reminder that public health successes are often distributed unevenly across different social strata. According to the latest findings from the NHS Wales Dental Epidemiology Programme, which examined over 8,500

Does Your Morning Commute Improve Your Brain Health?
Clinical & Pharma Does Your Morning Commute Improve Your Brain Health?

The realization that the mundane ritual of a daily commute could serve as a primary catalyst for cognitive enhancement challenges long-held perceptions of transit as a period of wasted time or environmental stress. Rather than viewing the minutes spent on a train or bus as a vacuum of productivity,

Global Medical Scrubs Market to Reach $85.8 Billion by 2033
Clinical & Pharma Global Medical Scrubs Market to Reach $85.8 Billion by 2033

The global medical scrubs industry is currently undergoing a massive transformation as healthcare facilities worldwide prioritize both staff comfort and strict infection control protocols. With the market projected to reach a valuation of $85.8 billion by 2033, the trajectory reflects a steady

England to Reward GPs for Improving Vaccination Rates
Clinical & Pharma England to Reward GPs for Improving Vaccination Rates

The Department of Health and Social Care has officially unveiled a landmark shift in the compensation framework for general practitioners in England to prioritize incremental progress over rigid performance targets. Starting with the 2026/2027 contract, the government is introducing "improvement

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later